Intracoronary streptokinase in acute myocardial infarction

Nature Reviews Cardiology

Volumn 7, Issue 2, 2010, Pages 67-69

  Armstrong, Paul W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOKINASE; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; CLINICAL EFFECTIVENESS; CORONARY ARTERY THROMBOSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; HUMAN; INTRACORONARY INFUSION; PATIENT CARE; PILOT STUDY; PRIORITY JOURNAL; RECANALIZATION; SHORT SURVEY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; HEART INFARCTION; MICROCIRCULATION; MULTIMODALITY CANCER THERAPY; NOTE; PATHOPHYSIOLOGY; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMBINED MODALITY THERAPY; CORONARY CIRCULATION; FIBRINOLYTIC AGENTS; HUMANS; MICROCIRCULATION; MYOCARDIAL INFARCTION; STREPTOKINASE; TREATMENT OUTCOME;

EID: 76449108492     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2009.230     Document Type: Short Survey

References (10)

1. Rentrop, P. et al. selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris. Circulation 63, 307-317 (1981).
2. Dewood, M. A. et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N. Engl. J. Med. 303, 897-902 (1980).
3. Gissi investigators Group. effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 327, 397-401 (1986).
4. sezer, M. et al. effect of intracoronary streptokinase administered immediately after primary percutaneous coronary intervention on long-term left ventricular infarct size, volumes, and function. J. Am. Coll. Cardiol. 54, 1065-1071 (2009).
5. Antman, e. M. et al. 2007 focused updated of the ACC/AHA 2004 guidelines for the management of patients with sT-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: Developed in collaboration with the Canadian Cardiovascular society endorsed by the American Academy of Family Physicians: 2007 writing group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with sT-elevation myocardial infarction, writing on behalf of the 2004 writing committee. Circulation 117, 296-329 (2008).
6. van de werf, F. et al. Management of acute myocardial infarction in patients presenting with persistent sT-segment elevation: the Task Force on the Management of sT-segment elevation Acute Myocardial infarction of the european society of Cardiology. Eur. Heart J. 29, 2909-2945 (2008).
7. Buller, C. e. et al. sT-segment recovery and outcome after primary percutaneous coronary intervention for sT-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial infarction (APeX-AMi) trial. Circulation 118, 1335-1346 (2008).
8. Fischell, T. A. Pharmaceutical interventions for the management of no-reflow. J. Invasive Cardiol. 20, 374-379 (2008).
9. Armstrong, P. w. & Collen, D. Fibrinolysis for acute myocardial infarction: Current status and new horizons for pharmacological reperfusion, part 1. Circulation 103, 2862-2866 (2001). (Pubitemid 32550078)
10. sezer, M. et al. intracoronary streptokinase after primary percutaneous coronary intervention. N. Engl. J. Med. 356, 1823-1834 (2007).